Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 37 studies | 50% ± 22% | |
| pericyte | 30 studies | 51% ± 22% | |
| smooth muscle cell | 23 studies | 61% ± 22% | |
| connective tissue cell | 12 studies | 47% ± 22% | |
| myofibroblast cell | 8 studies | 43% ± 16% | |
| type II pneumocyte | 7 studies | 29% ± 14% | |
| type I pneumocyte | 6 studies | 20% ± 4% | |
| epithelial cell | 5 studies | 27% ± 11% | |
| astrocyte | 4 studies | 64% ± 9% | |
| adventitial cell | 4 studies | 55% ± 18% | |
| ciliated cell | 4 studies | 41% ± 21% | |
| kidney loop of Henle epithelial cell | 3 studies | 44% ± 9% | |
| luminal cell of prostate epithelium | 3 studies | 18% ± 1% | |
| basal cell | 3 studies | 25% ± 10% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| uterus | 4 studies | 29% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 98% | 9491.16 | 239 / 245 | 98% | 142.66 | 493 / 502 |
| intestine | 87% | 6717.46 | 844 / 966 | 94% | 156.39 | 498 / 527 |
| thymus | 99% | 13182.85 | 648 / 653 | 81% | 107.96 | 492 / 605 |
| lung | 99% | 10809.54 | 573 / 578 | 77% | 57.92 | 884 / 1155 |
| kidney | 87% | 8448.85 | 77 / 89 | 87% | 81.62 | 783 / 901 |
| esophagus | 85% | 17482.31 | 1235 / 1445 | 83% | 80.17 | 151 / 183 |
| bladder | 100% | 12596.14 | 21 / 21 | 65% | 86.82 | 330 / 504 |
| pancreas | 70% | 2726.64 | 230 / 328 | 93% | 89.22 | 165 / 178 |
| stomach | 56% | 5568.19 | 202 / 359 | 92% | 143.21 | 264 / 286 |
| uterus | 99% | 9621.12 | 169 / 170 | 48% | 43.36 | 221 / 459 |
| breast | 97% | 9423.36 | 446 / 459 | 47% | 26.84 | 530 / 1118 |
| ovary | 56% | 3248.54 | 100 / 180 | 75% | 62.71 | 324 / 430 |
| skin | 67% | 3993.38 | 1213 / 1809 | 48% | 57.69 | 226 / 472 |
| blood vessel | 100% | 36608.65 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 100% | 12459.14 | 1198 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 94% | 115.20 | 75 / 80 |
| heart | 83% | 5106.64 | 711 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 69% | 25.61 | 20 / 29 |
| adrenal gland | 11% | 391.02 | 29 / 258 | 46% | 24.31 | 105 / 230 |
| liver | 4% | 101.17 | 8 / 226 | 39% | 27.91 | 160 / 406 |
| brain | 2% | 66.74 | 54 / 2642 | 31% | 14.81 | 222 / 705 |
| tonsil | 0% | 0 | 0 / 0 | 33% | 9.84 | 15 / 45 |
| spleen | 22% | 798.50 | 54 / 241 | 0% | 0 | 0 / 0 |
| muscle | 5% | 222.40 | 42 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0046688 | Biological process | response to copper ion |
| GO_0019430 | Biological process | removal of superoxide radicals |
| GO_0001666 | Biological process | response to hypoxia |
| GO_0097746 | Biological process | blood vessel diameter maintenance |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005796 | Cellular component | Golgi lumen |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005576 | Cellular component | extracellular region |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0008201 | Molecular function | heparin binding |
| GO_0005507 | Molecular function | copper ion binding |
| GO_0004784 | Molecular function | superoxide dismutase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0060090 | Molecular function | molecular adaptor activity |
| Gene name | SOD3 |
| Protein name | Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) Superoxide dismutase 3 |
| Synonyms | |
| Description | FUNCTION: Protect the extracellular space from toxic effect of reactive oxygen intermediates by converting superoxide radicals into hydrogen peroxide and oxygen. |
| Accessions | ENST00000382120.4 M0R1V4 ENST00000598411.1 P08294 |